Cargando…
Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance
Chemotherapy is still a main option for cancer therapy, but its efficacy is often unsatisfying due to multidrug resistance (MDR). The tumor microenvironment is considered a dominant factor causing MDR. Stimuli-responsive nanomedicines exhibit many superiorities for reversal of MDR. As smart systems,...
Autores principales: | Zhou, Lei, Wang, Hao, Li, Yaping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817110/ https://www.ncbi.nlm.nih.gov/pubmed/29463999 http://dx.doi.org/10.7150/thno.22679 |
Ejemplares similares
-
Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress
por: Ortíz, Raúl, et al.
Publicado: (2021) -
Recent Trends in Nanomedicine-Based Strategies to Overcome Multidrug Resistance in Tumors
por: Khan, Muhammad Muzamil, et al.
Publicado: (2022) -
Nanomedicines for Overcoming Cancer Drug Resistance
por: Hu, Tingting, et al.
Publicado: (2022) -
Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance
por: Wang, Shuanghu, et al.
Publicado: (2017) -
Stimuli‐responsive crosslinked nanomedicine for cancer treatment
por: Xue, Xiangdong, et al.
Publicado: (2022)